Chain Conference 2025 Nigeria, Deepening West African Market Layout for a New Chapter of Cooperation
[Lagos, August 28, 2025] As a leading Chinese supplier of pharmaceutical APIs and formulations, Huarong Pharmaceutical recently showcased its core products and localized solutions at the Supply Chain Conference 2025 held in Lagos, Nigeria. With the theme "Harnessing Local Capacity: Building Resilient and Self-Reliant Supply Chains in Africa", this conference is the largest pharmaceutical trade event in West Africa, attracting over 250 enterprises from more than 30 countries and 4,000+ pharmaceutical industry professionals. With its internationally compliant product portfolio and in-depth localized cooperation solutions, Huarong Pharmaceutical became a focal point of the conference.
As Africa's largest economy, Nigeria has a huge market of over 200 million people, with its pharmaceutical market size reaching 4.5 billion US dollars. However, 80% of its pharmaceuticals rely on imports, especially in antibiotics, antimalarial drugs and other fields where there is a huge supply-demand gap. The Nigerian government recently launched a localized production policy aiming to "increase pharmaceutical self-sufficiency rate to 70%", providing policy dividends and market opportunities for international pharmaceutical enterprises. Huarong Pharmaceutical's participation in this conference is precisely a strategic layout targeting the West African market, aiming to establish long-term and stable cooperation channels by directly connecting with African purchasers, medical institutions and government departments.
During the conference, Huarong Pharmaceutical focused on showcasing four categories of core essential medicines: First, antibiotic APIs such as Chloramphenicol and Amoxicillin that have passed USP, EP and CP triple certifications, which will be mainly used for the treatment of community-acquired infections in the future; Second, Paracetamol, the world's most widely used antipyretic and analgesic, with a purity of over 99.5% that meets international pharmacopoeia standards, which can meet the rigid demand for fever and pain relief drugs in the African market; Third, Metronidazole formulations for the treatment of intestinal infections, using easy-to-store film-coated tablets that are suitable for the logistics conditions in some parts of Africa; Fourth, fixed-dose combination preparations for common diseases in Africa, such as Amoxicillin-Clavulanate Potassium combination, which optimizes medication convenience.
Notably, during the conference, Huarong Pharmaceutical held in-depth negotiations with leading local pharmaceutical factories in Nigeria on the supply of Amoxicillin and Paracetamol APIs. The two sides initially reached a consensus on key terms such as product quality standards and supply cycles, and plan to advance substantive cooperation in the follow-up; at the same time, it conducted special docking with the Lagos State Government Health Department on the "Essential Medicines Localized Filling Project", exchanging views on production line construction and capacity planning, laying the foundation for subsequent cooperation.
As a representative of Chinese enterprises, Merlin, International Director of Huarong Pharmaceutical, delivered a speech at the main forum of the conference alongside guest speaker Dr. Abdu Mukhtar, National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain (PvAc). Merlin stated: "The African pharmaceutical market has huge development potential, and the accessibility of essential medicines is the key to improving local public health standards. We not only bring high-quality products, but also output sustainable localized solutions." According to him, to ensure the smooth connection of products to the African market, Huarong is cooperating with international testing institutions such as SGS to establish a full-life-cycle quality traceability system for products, strictly meeting the requirements of the African market for pharmaceutical safety.
During the conference, Dr. Abdu Mukhtar, National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain (PvAc), visited Huarong Pharmaceutical's exhibition area and spoke highly of its product quality control system and localized cooperation concepts. He pointed out: "The African pharmaceutical market needs more enterprises like Huarong that have both international standards and localized vision. We look forward to carrying out in-depth cooperation in technology transfer, capacity cooperation and other fields in the future to jointly advance the goal of building resilient and self-reliant supply chains in Africa."
During this trip to Africa, Huarong Pharmaceutical also conducted extensive docking with purchasers from member countries of the Economic Community of West African States (ECOWAS) such as Ghana and Côte d'Ivoire during the conference, conducting in-depth negotiations on 15 potential cooperation projects involving an amount of over 5 million US dollars. Next, the enterprise plans to set up a regional office in Lagos, and form a service network composed of local pharmaceutical experts, compliance consultants and logistics teams to provide customers with one-stop services from product consultation, supply chain solutions to technical support, promoting the transformation and implementation of intentional cooperation.
With the adjustment of the global pharmaceutical industry pattern, emerging markets have become a new engine for growth. Through this conference, Huarong Pharmaceutical has further consolidated its layout in the African market. Its three-dimensional model of "products + services + localized production" not only opens up new growth space for the enterprise, but also contributes Chinese strength to improving Africa's pharmaceutical self-sufficiency capacity and local public health conditions.